Case Comprehensive Cancer Center: Carcinoma, Renal Cell trials

The registry lists 16 Carcinoma, Renal Cell studies with Case Comprehensive Cancer Center as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 10Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial NephrectomyNot yet recruitingNCT05725421Not applicable
• Axitinib Given on an Individualized Schedule for Metastatic Renal Cell CancerCompletedNCT02579811Phase 2Results posted
• Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney CancerTerminatedNCT01740154Not applicableResults posted
• Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone SurgeryCompletedNCT01158534Phase 2Results posted
• Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney CancerCompletedNCT01158521Phase 2Results posted
• Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney CancerCompletedNCT01158222Phase 2Results posted
• Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or BevacizumabCompletedNCT00866320Phase 2Results posted
• Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by SurgeryCompletedNCT00459979Phase 2Results posted
• Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in CancerActive, not recruitingNCT04620603Phase 1
• Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and NivolumabCompletedNCT03126331Phase 2
• A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell CancerWithdrawnNCT02307474Not applicable
• Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney CancerWithdrawnNCT00908739
• Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney CancerCompletedNCT00278174Phase 2
• Interleukin-2 in Treating Patients With Metastatic Kidney CancerCompletedNCT00006864Phase 4
• Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and MetastasesCompletedNCT00006255Phase 2
• Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney CancerCompletedNCT00003928Phase 2